Modulation of host cell metabolism by Trypanosoma cruzi

S A Morris1, H B Tanowitz, J P Bilezikian

  • 1Department of Pathology and Medicine, Albert Einstein College ofMedicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.

Insights

Chagas disease, caused by Trypanosoma cruzi, may target endothelial cells. Researchers suggest parasite metabolism interference leads to endothelial cell dysfunction in acute and chronic Chagas disease.

Area of Science:

  • Infectious Diseases
  • Cell Biology
  • Parasitology

Background:

  • Chagas disease is a complex parasitic infection caused by Trypanosoma cruzi.
  • The disease affects millions globally, leading to significant morbidity and mortality.
  • Current understanding of Chagas disease pathogenesis, particularly endothelial cell involvement, requires further elucidation.

Purpose of the Study:

  • To investigate the role of endothelial cells as a primary target in Chagas disease.
  • To explore the mechanisms underlying endothelial cell dysfunction in both acute and chronic phases of the infection.
  • To elucidate the impact of Trypanosoma cruzi amastigotes on host cell metabolism.

Main Methods:

  • The study focuses on the interaction between Trypanosoma cruzi amastigotes and host endothelial cells.
  • Investigated the metabolic pathways within endothelial cells upon infection.
  • Utilized cellular and molecular techniques to assess endothelial cell function.

Main Results:

  • Evidence suggests endothelial cells are a key target for Trypanosoma cruzi infection.
  • Amastigote-associated interference with host cell metabolism is implicated in endothelial cell dysfunction.
  • Abnormalities in microcirculation are linked to endothelial cell dysfunction in Chagas disease.

Conclusions:

  • Endothelial cell dysfunction is a critical factor in the pathogenesis of Chagas disease.
  • Trypanosoma cruzi amastigotes directly impact endothelial cell metabolism, contributing to disease progression.
  • Targeting endothelial cell dysfunction may offer new therapeutic strategies for Chagas disease.

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Microbial Interactions: Parasitism01:22

Microbial Interactions: Parasitism

Parasitism is a form of microbial interaction in which parasitic microbes exploit a host organism for nutrients and shelter, often at the host's expense. Unlike mutualistic relationships, where both organisms benefit, parasitism benefits only the parasite and harms the host.Classification of ParasitesMicrobial parasites are broadly classified based on their location relative to the host.Ectoparasites remain on the host’s surface, such as the skin or outer tissues, drawing nutrients...
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...